Synopsis
Synopsis
0
JDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 9 Alpha-fluorocortisol Acetate
2. 9-fluoro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate
3. Cortineff
4. Florinef
5. Fludrocortisone 21-acetate
6. Fluorocortisol Acetate
1. 514-36-3
2. Scherofluron
3. Cortineff
4. Fludrocortisone 21-acetate
5. Florinef Acetate
6. Alflorone Acetate
7. Fluorocortisol Acetate
8. Cortef-f
9. F-cortef Acetate
10. Fluorocortisone Acetate
11. Fluohydrocortisone Acetate
12. Fludrocortisoneacetate
13. 9alpha-fluorohydrocortisone Acetate
14. Nsc-15186
15. U 4845
16. 9alpha-fluorohydrocortisone 21-acetate
17. V47if0pvh4
18. 514-36-3 (acetate)
19. Chebi:5102
20. 2-((8s,9r,10s,11s,13s,14s,17r)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl Acetate
21. Pregn-4-ene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-,(11b)-
22. [2-[(8s,9r,10s,11s,13s,14s,17r)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Acetate
23. (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl Acetate
24. 9alpha-fluoro-11beta,17alpha,21-trihydroxy-pregn-4-en-3,20-dione 21-acetate
25. Mls002638417
26. Fludrocortisone (acetate)
27. Mfcd00864160
28. Unii-v47if0pvh4
29. Fludrocortisone Acetate [jan]
30. 9-fluoro-11-beta,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate
31. Fludrocortisonacetat
32. Cortisol, 9-fluoro-, 21-acetate
33. Fludrocortisone Acetate [usp:jan]
34. 9-alpha-fluorohydrocortisone Acetate
35. Einecs 208-180-4
36. Nsc 15186
37. Fludrocortisoni Acetas
38. Fludrocortisone-acetate
39. 9-alpha-fluorohydrocortisone-21-acetate
40. Brn 2067486
41. Florinef Acetate (tn)
42. 9a-fluorcortisol Acetate
43. 9a-fluorocortisol Acetate
44. Prestwick0_000281
45. Prestwick1_000281
46. Prestwick2_000281
47. 9-fluoro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate
48. 9a-fludrocortisone Acetate
49. Acetic Acid Fludrocortisone
50. Schembl4737
51. Corticosterone, 9-fluoro-17-hydroxy-, 21-acetate
52. Spbio_002401
53. 9.alpha.-fluorocortisol Acetate
54. Chembl1201010
55. Dtxsid2023062
56. Fludrocortisone Acetate, >=98%
57. Hy-b1203a
58. Fluorhydrocortisone Acetate
59. Hms1568j04
60. Nsc15186
61. Zinc3977990
62. Fludrocortisone Acetate (jp17/usp)
63. Lmst02030122
64. S3659
65. 9.alpha.-fluorohydrocortisone Acetate
66. Akos015963145
67. Ccg-268914
68. Cs-4833
69. Ds-3879
70. Fludrocortisone Acetate [mart.]
71. Fludrocortisone Acetate [vandf]
72. Fludrocortisone Acetate [usp-rs]
73. Fludrocortisone Acetate [who-dd]
74. Fludrocortisone Acetate [who-ip]
75. Pregn-4-ene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11.beta.)-
76. Fludrocortisone 21-acetate [mi]
77. 9.alpha.-fluorohydrocortisone 21-acetate
78. 9.alpha.-fluorohydrocortisone-21-acetate
79. Ac-18903
80. Fludrocortisone Acetate [orange Book]
81. Fludrocortisoni Acetas [who-ip Latin]
82. Fludrocortisone Acetate [ep Monograph]
83. C08186
84. D00986
85. Fludrocortisone Acetate [usp Monograph]
86. Q-201121
87. 9
88. A-fludrocortisone Acetate;9
89. A-fluorcortisol Acetate
90. Fludrocortisone Acetate 100 Microg/ml In Acetonitrile
91. Q27106657
92. Wln: L E5 B666 Ov Mutj A1 Bf Cq E1 Fv1ov1 Fq
93. 9-fluoro-11beta,17-dihydroxy-3,20-dioxopregn-4-en-21-yl Acetate
94. Pregn-4-ene-3, 9-fluoro-11.beta.,17,21-trihydroxy-, 21-acetate
95. 9-fluoro-11
96. A, 17, 21-trihydroxypregn-4-ene-3, 20-dione 21-acetate
97. Fludrocortisone Acetate, European Pharmacopoeia (ep) Reference Standard
98. Fludrocortisone Acetate, United States Pharmacopeia (usp) Reference Standard
99. Pregn-4-ene-3, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11.beta.)-
100. Pregn-4-ene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-, 21-acetate
101. Pregn-4-ene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-, 21-acetate
102. 9-fluoro-11.beta.,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate
103. Pregn-4-ene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11beta)-
104. [2-[(9r,10s,11s,13s,17r)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Acetate
Molecular Weight | 422.5 g/mol |
---|---|
Molecular Formula | C23H31FO6 |
XLogP3 | 1.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 422.21046687 g/mol |
Monoisotopic Mass | 422.21046687 g/mol |
Topological Polar Surface Area | 101 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 838 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Fludrocortisone acetate |
PubMed Health | Fludrocortisone Acetate (By mouth) |
Drug Classes | Diagnostic Agent, Adrenocortical Function, Endocrine-Metabolic Agent |
Drug Label | Fludrocortisone Acetate Tablets, USP contains fludrocortisone acetate, a synthetic adrenocortical steroid possessing very potent mineralocorticoid properties and high glucocorticoid activity; it is used only for its mineralocorticoid effects. The che... |
Active Ingredient | Fludrocortisone acetate |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.1mg |
Market Status | Prescription |
Company | Hikma Pharms; Impax Labs; Barr |
2 of 2 | |
---|---|
Drug Name | Fludrocortisone acetate |
PubMed Health | Fludrocortisone Acetate (By mouth) |
Drug Classes | Diagnostic Agent, Adrenocortical Function, Endocrine-Metabolic Agent |
Drug Label | Fludrocortisone Acetate Tablets, USP contains fludrocortisone acetate, a synthetic adrenocortical steroid possessing very potent mineralocorticoid properties and high glucocorticoid activity; it is used only for its mineralocorticoid effects. The che... |
Active Ingredient | Fludrocortisone acetate |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.1mg |
Market Status | Prescription |
Company | Hikma Pharms; Impax Labs; Barr |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
81
PharmaCompass offers a list of Fludrocortisone Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fludrocortisone Acetate manufacturer or Fludrocortisone Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fludrocortisone Acetate manufacturer or Fludrocortisone Acetate supplier.
PharmaCompass also assists you with knowing the Fludrocortisone Acetate API Price utilized in the formulation of products. Fludrocortisone Acetate API Price is not always fixed or binding as the Fludrocortisone Acetate Price is obtained through a variety of data sources. The Fludrocortisone Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cortineff manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cortineff, including repackagers and relabelers. The FDA regulates Cortineff manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cortineff API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cortineff manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cortineff supplier is an individual or a company that provides Cortineff active pharmaceutical ingredient (API) or Cortineff finished formulations upon request. The Cortineff suppliers may include Cortineff API manufacturers, exporters, distributors and traders.
click here to find a list of Cortineff suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cortineff DMF (Drug Master File) is a document detailing the whole manufacturing process of Cortineff active pharmaceutical ingredient (API) in detail. Different forms of Cortineff DMFs exist exist since differing nations have different regulations, such as Cortineff USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cortineff DMF submitted to regulatory agencies in the US is known as a USDMF. Cortineff USDMF includes data on Cortineff's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cortineff USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cortineff suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cortineff Drug Master File in Korea (Cortineff KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cortineff. The MFDS reviews the Cortineff KDMF as part of the drug registration process and uses the information provided in the Cortineff KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cortineff KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cortineff API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cortineff suppliers with KDMF on PharmaCompass.
A Cortineff CEP of the European Pharmacopoeia monograph is often referred to as a Cortineff Certificate of Suitability (COS). The purpose of a Cortineff CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cortineff EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cortineff to their clients by showing that a Cortineff CEP has been issued for it. The manufacturer submits a Cortineff CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cortineff CEP holder for the record. Additionally, the data presented in the Cortineff CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cortineff DMF.
A Cortineff CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cortineff CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cortineff suppliers with CEP (COS) on PharmaCompass.
A Cortineff written confirmation (Cortineff WC) is an official document issued by a regulatory agency to a Cortineff manufacturer, verifying that the manufacturing facility of a Cortineff active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cortineff APIs or Cortineff finished pharmaceutical products to another nation, regulatory agencies frequently require a Cortineff WC (written confirmation) as part of the regulatory process.
click here to find a list of Cortineff suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cortineff as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cortineff API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cortineff as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cortineff and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cortineff NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cortineff suppliers with NDC on PharmaCompass.
Cortineff Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cortineff GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cortineff GMP manufacturer or Cortineff GMP API supplier for your needs.
A Cortineff CoA (Certificate of Analysis) is a formal document that attests to Cortineff's compliance with Cortineff specifications and serves as a tool for batch-level quality control.
Cortineff CoA mostly includes findings from lab analyses of a specific batch. For each Cortineff CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cortineff may be tested according to a variety of international standards, such as European Pharmacopoeia (Cortineff EP), Cortineff JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cortineff USP).